ロード中...
Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer
SIMPLE SUMMARY: Overactivation of the human epidermal growth factor receptor 2 (HER2) is one of the main drivers of tamoxifen resistance in estrogen receptor (ER)-positive breast cancer patients. Combined targeting of HER2 and ER, however, has yielded disappointing results in the clinical setting. T...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7961649/ https://ncbi.nlm.nih.gov/pubmed/33800852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13051132 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|